REG - Iconic Labs PLC - Conversion of Securities

Iconic LabsAnnouncement

30/11/2022 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221130:nRSd0951Ia&default-theme=true

RNS Number : 0951I  Iconic Labs PLC  30 November 2022

30 November 2022

 

Iconic Labs Plc ("Iconic") In Administration

 

EHGOSF Subscribes to a £ 150,000 Third Tranche Under £ 3 Million Financing
Facility

 

EHGOSF has subscribed to a £ 150,000 third tranche of convertible notes under
the £ 3 million financing facility that was entered into on 28 September
2022.

 

In exchange, Iconic will issue 150 convertible notes to EHGOSF along with
468,750,000 warrants with an exercise price of £ 0.00016.

 

The funds under this third tranche shall be used to meet Iconic's obligations
to critical and preferential creditors under the CVA and for operational
purposes as Iconic seeks to get its trading suspension lifted as soon as
possible.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CONEAFFEDEXAFFA